Advanced Search

Refine my results

Document type

Institution

Specific Collection

Language

Author

Domain

Keyword

Sorted by: Date of deposit
2 results 1
Université de Fribourg

Vascular response to everolimus- and biolimus-eluting coronary stents versus everolimus-eluting bioresorbable scaffolds – an optical coherence tomography substudy of the EVERBIO II trial

Kallinikou, Zacharenia ; Arroyo, Diego ; Togni, Mario ; Lehmann, Sonja ; Corpataux, Noé ; Cook, Malica ; Müller, Olivier ; Baeriswyl, Gérard ; Stauffer, Jean-Christophe ; Goy, Jean-Jacques ; Puricel, Serban ; Cook, Stéphane

In: Swiss Medical Weekly, 2016, p. -

QUESTIONS UNDER STUDY: Head-to-head optical coherence tomography (OCT) data comparing metallic stents with bioresorbable vascular scaffolds (BVS) are lacking. This study assessed vascular healing at 9-month follow-up after implantation of everolimus- and biolimus-eluting stents (EES BES) and everolimus-eluting BVS.METHODS: OCT was performed in 74 patients enrolled in the EVERBIO II (NCT01711931)...

Université de Fribourg

Comparison of everolimus-eluting and biolimus-eluting coronary stents with everolimus-eluting bioresorbable scaffold: study protocol of the randomized controlled EVERBIO II trial

Arroyo, Diego ; Togni, Mario ; Puricel, Serban ; Gerard, Baeriswyl ; Sonja, Lehmann ; Corpataux, Noé ; Villeneuve, Hélène ; Boute, Estelle ; Stauffer, Jean-Christophe ; Goy, Jean-Jacques ; Cook, Stéphane

In: Trials, 2014, vol. 15, no. 1, p. 9

Background: Second-generation everolimus-eluting stents (EES) and third generation biolimus-eluting stents (BES) have been shown to be superior to first-generation paclitaxel-eluting stents (PES) and second-generation sirolimus-eluting stents (SES). However, neointimal proliferation and very late stent thrombosis is still an unresolved issue of drug-eluting stent (DES) implantation overall. The...

2 results 1